Multiple genetic changes are required for efficient immortalization of different subtypes of normal human mammary epithelial cells

Radiation Research

Volumn 155, Issue 1, 2001, Pages 143-150

  Ratsch, Sarah B ^a   Gao, Qingshen ^a   Srinivasan, Seetha ^a   Wazer, David E ^a   Band, Vimla ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST; BREAST TUMOR; CELL LINE; CELL TRANSFORMATION; CYTOLOGY; EPITHELIUM CELL; FEMALE; GENETICS; HUMAN; PHYSIOLOGY; REVIEW; VIROLOGY; VIRUS CELL TRANSFORMATION;

BREAST; BREAST NEOPLASMS; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; EPITHELIAL CELLS; FEMALE; HUMANS;

EID: 0035219028     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/0033-7587(2001)155[0143:MGCARF]2.0.CO;2     Document Type: Article

References (51)

1. S. L. Hammond, R. G. Ham and M. R. Stampfer, Serum-free growth of human mammary epithelial cells: rapid clonal growth in defined medium and extended serial passage with pituitary extract. Proc. Natl. Acad. Sci. USA 81, 5435-5439 (1984).
2. V. Band and R. Sager, Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. Proc. Natl. Acad. Sci. USA 86, 1249-1253 (1989).
3. M. R. Stampfer and J. C. Bartley, Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo(a)pyrene. Proc. Natl. Acad. Sci. USA 82, 2394-2398 (1985).
4. D. E. Wazer, Q. Chu, X. L. Liu, Q. Gao, H. Safaii and V. Band, Loss of p53 protein during radiation transformation of primary human mammary epithelial cells. Mol. Cell. Biol. 14, 2468-2478 (1994).
5. X. L. Liu, D. E. Wazer, K. Watanabe and V. Band, Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast cancer progression. Cancer Res. 56, 3371-3379 (1996).
6. R. Sager, Expression genetics in cancer: shifting the focus from DNA to RNA. Proc. Natl. Acad. Sci. USA 94, 952-955 (1997).
7. J. Goyal, K. M. Smith, J. M. Cowan, D. E. Wazer, S. W. Lee and V. Band, The role for NES1 serine protease as a novel tumor suppressor. Cancer Res. 58, 4782-4786 (1998).
8. R. Sager, Resistance of human cells to oncogenic transformation. Cancer Cells 2, 487-494 (1984).
9. J. Taylor-Papadimitriou, F. Berdichevsky, B. D'Souza and J. Burchell, Human models of breast cancer. Cancer Surv. 16, 59-78 (1993).
10. H. Zur Hausen, Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Current Top. Microbiol. Immunol. 186, 131-156 (1994).
11. K. Munger, W. C. Phelps, V. Bubb, P. M. Howley and R. Schlegel, The E6 and E7 genes of the human papilloma virus type 16 together are necessary and sufficient for the transformation of primary human keratinocytes. J. Virol. 63, 4417-4421 (1989).
12. S. Watanabe, T. Kanda and K. Yoshiike, Human papillomavirus type 16 transformation of primary human embryonic fibroblasts requires expression of open reading frames E6 and E7. J. Virol. 63, 965-969 (1989).
13. V. Band, D. Zajchowski, V. Kulesa and R. Sager, Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements. Proc. Natl. Acad. Sci. USA 87, 463-467 (1990).
14. D. E. Wazer, X. L. Liu, Q. Chu, Q. Gao and V. Band, Immortalization of distinct human mammary epithelial cell types by human papilloma virus-16 E6 or E7. Proc. Natl. Acad. Sci. USA 92, 3687-3691 (1995).
15. M. Scheffner, B. A. Werness, J. M. Huibregtse, A. J. Levine and P. M. Howley, The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63, 1129-1136 (1990).
16. A. J. Levine, P53, the cellular gatekeeper for growth and division. Cell 88, 323-331 (1997).
17. A. Hartmann, H. Blaszyk, J. S. Kovach and S. S. Sommer, The molecular epidemiology of p53 gene mutations in human breast cancer. Trends Genet. 13, 27-33 (1997).
18. D. Malkin, F. P. Li, L. C. Strong, J. F. Fraumeni, Jr., C. E. Nelson, D. H. Kim, J. Kassel, M. A. Gryka, F. Z. Bischoff and M. A. Tainsky, Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250, 1233-1238 (1990).
19. V. Band, S. Dalal, L. Delmolino and E. J. Androphy, Enhanced degradation of p53 protein in HPV-6 and BPV-1 E6-immortalized human mammary epithelial cells. EMBO J. 12, 1847-1852 (1993).
20. S. Dalai, Q. Gao, E. J. Androphy and V. Band, Mutational analysis of human papillomavirus type 16 E6 demonstrates that p53 degradation is necessary for immortalization of mammary epithelial cells. J. Virol. 70, 683-688 (1996).
21. Y. Liu, J. J. Chen, Q. Gao, S. Dalai, Y. Hong, C. P. Mansur, V. Band and E. J. Androphy, Multiple functions of human papillomavirus type 16 E6 contribute to the immortalization of mammary epithelial cells. J. Virol. 73, 7297-7307 (1999).
22. T. Kiyono, S. A. Foster, J. I. Koop, J. K. McDougall, D. A. Galloway and A. J. Klingelhutz, Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396, 84-88 (1998).
23. Q. Gao, S. H. Hauser, X. L. Liu, D. E. Wazer, H. Madoc-Jones and V. Band, Mutant p53-induced immortalization of primary human mammary epithelial cells. Cancer Res. 56, 3129-3133 (1996).
24. L. S. Gollahon and J. W. Shay, Immortalization of human mammary epithelial cells transfected with mutant p53 (273his). Oncogene 12, 715-725 (1996).
25. Y. Cao, Q. Gao, D. E. Wazer and V. Band, Abrogation of wild-type p53-mediated transactivation is insufficient for mutant p53-induced immortalization of normal human mammary epithelial cells. Cancer Res. 57, 5584-5589 (1997).
26. A. J. Klingelhutz, S. A. Foster and J. K. McDougall, Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380, 79-82 (1996).
27. J. Wang, L. Y. Xie, S. Allan, D. Beach and G. J. Hannon, Myc activates telomerase. Genes Dev. 12, 1769-1774 (1998).
28. C. W. Greider, Telomerase activation. One step on the road to cancer? Trends Genet. 15, 109-112 (1999).
29. K. J. Wu, C. Grandori, M. Amacker, N. Simon-Vermot, A. Polack, J. Lingner and R. Dalla-Favera, Direct activation of TERT transcription by c-MYC. Nat. Genet. 21, 220-224 (1999).
30. J. J. Chen, C. E. Reid, V. Band and E. J. Androphy, Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein. Science 269, 529-531 (1995).
31. X. Tong and P. M. Howley, The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton. Proc. Natl. Acad. Sci. USA 94, 4412-4417 (1997).
32. T. Kiyono, A. Hiraiwa, M. Fujita, Y. Hayashi, T. Akiyama and M. Ishibashi, Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. Proc. Natl. Acad. Sci. USA 94, 11612-11617 (1997).
33. L. V. Ronco, A. Y. Karpova, M. Vidai and P. M. Howley, Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev. 12, 2061-2072 (1998).
34. M. Thomas and L. Banks, Inhibition of Bak-induced apoptosis by HPV-18 E6. Oncogene 17, 2943-2954 (1998).
35. C. Kuhne and L. Banks, E3-ubiquitin ligase/E6-AP links multicopy maintenance protein 7 to the ubiquitination pathway by a novel motif, the L2G box. J. Biol. Chem. 273, 34302-34309 (1998).
36. Q. Gao, S. Srinivasan, S. N. Boyer, D. E. Wazer and V. Band, The E6 oncoproteins of high-risk papillomaviruses bind to a novel putative GAP protein, E6TP1, and target it for degradation. Mol. Cell. Biol. 19, 733-744 (1999).
37. D. Patel, S. M. Huang, L. A. Baglia and D. J. McCance, The E6 protein of human papillomavirus type 16 binds to and inhibits coactivation by CBP and P300. EMBO J. 18, 5061-5072 (1999).
38. H. Zimmermann, R. Degenkolbe, H. U. Bernard and M. J. O'Connor, The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/ p300. J. Virol. 73, 6209-6019 (1999).
39. J. M. Huibregtse, M. Scheffner and P. M. Howley, A cellular oncoprotein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J. 10, 4129-4135 (1991).
40. A. J. Brenner, M. R. Stampfer and C. M. Aldaz, Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation. Oncogene 17, 199-205 (1998).
41. S. A. Foster, D. J. Wong, M. T. Barrett and D. A. Galloway, Inactivation of p16 in human mammary epithelial cells by CpG island methylation. Mol. Cell. Biol. 18, 1793-1801 (1998).
42. N. Dyson, P. M. Howley, K. Munger and E. Harlow, The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243, 934-936 (1989).
43. S. N. Boyer, D. E. Wazer and V. Band, E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res. 56, 4620-4624 (1996).
44. W. C. Phelps, K. Munger, C. L. Yee, J. A. Barnes and P. M. Howley, Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein. J. Virol. 66, 2418-2427 (1992).
45. N. Dyson, P. Guida, K. Munger and E. Harlow, Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins. J. Virol. 66, 6893-6902 (1992).
46. D. L. Jones, R. M. Alani and K. Munger, The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2. Genes Dev. 11, 2101-2111 (1997).
47. K. Zerfass-Thome, W. Zwerschke, B. Mannhardt, R. Tindle, J. W. Botz and P. Jansen-Durr, Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein. Oncogene 13, 2323-2330 (1996).
48. E. Berezutskaya and S. Bagchi, The human papillomavirus E7 oncoprotein functionally interacts with the S4 subunit of the 26 S proteasome. J Biol. Chem. 272, 30135-30140 (1997).
49. W. Zwerschke, S. Mazurek, P. Massimi, L. Banks, E. Eigenbrodt and P. Jansen-Durr, Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein. Proc. Natl. Acad. Sci. USA 96, 1291-1296 (1999).
50. A. Brehm, S. J. Nielsen, E. A. Miska, D. J. McCance, J. L. Reid, A. J. Bannister and T. Kouzarides, The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth EMBO J. 18, 2449-2458 (1999).
51. J. W. Shay, G. Tomlinson, M. A. Piatyszek and L. S. Gollahon, Spontaneous in vitro immortalization of breast epithelial cells from a patient with Li-Fraumeni syndrome. Mol. Cell Biol. 15, 425-432 (1995).